The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models. Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation. The increased tumor burden is correlated with attenuated levels of IL-1beta and IL-18 at the tumor site. To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice. Nlrp3(-/-) mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3(-/-) mice than in Pycard(-/-) or Casp1(-/-) animals. No significant differences were observed in disease progression or outcome in Nlrc4(-/-) mice compared with similarly treated wild-type animals. Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis. These data suggest that the inflammasome functions as an attenuator of colitis and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 2×
“Two families of innate immune receptors, the Tolllike receptors (TLRs) and the nu cleotidebinding domain, leucinerichrepeat containing (NLR) proteins, have emerged as essential mediators of gastrointestinal inflam mation and homeostasis (Akira et al., 2006; Franchi et al., 2006).”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 4×
“How ever, damage to the colonic epithelial cell layer in the colon initiates the release of various DAMP signals, and DAMPs have the potential to activate the NLRP3 inflam masome.”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 6×
“Jenny P.-Y. Ting: panyun@med.unc.edu Abbreviations used: AOM, azoxymethane; ASC/ PYCARD, Apoptotic Speck protein containing a CARD; CAC, colitisassociated cancer; CRC, colorectal cancer; DAMP, damageassociated molecular pattern; DSS, dextran sulfate sodium; HAI, Histologi cal Activity Index; IBD, inflam matory bowel d…”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“AIM2 has been shown to form of commensal normal flora in the intestine (RakoffNahoum et al., 2004; Araki et al., 2005; Fukata et al., 2005).”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“Patients suffering from UC demonstrate a significantly increased risk of colorectal cancer (CRC), which seems to be associated with both the duration of the disease and the degree of mucosal inflammation (Eaden et al., 2001).”
BackgroundAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 16×
“Organ culture supernatants were harvested after incubation for 24 h and IL1, IL18, and TNF levels were determined by ELISA.”
InfluentialIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 2×
“…functional Nlrp3, Nlrc4, Pycard, and caspase1 (Casp1) has been previously described (R. Flavell, Yale University, New Haven, CT; V. Dixit, Genentech, Inc., San Francisco, CA; F. Sutterwala, University of Iowa, Iowa City, IA; Adachi et al., 1998; Mariathasan et al., 2004; Sutterwala et al., 2006).”
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839 · cited 5×
“In ad dition to NLRP3, other NLRs, such as NLRC4, can form NLRP3independent inflammasome in response to specific stimuli, such as flagellin (Mariathasan et al., 2004).”
BackgroundInfluential
Cited by
Items 201–300 of 849
Ippagunta, S. K., Malireddi, R. K. S., Shaw, P. J., Neale, G. A., Walle, L. V., Green, D. R., Fukui, Y., Lamkanfi, M., & Kanneganti, T.-D. (2011) · Nature Immunology · doi:10.1038/ni.2095 · Cited by 113
Sun, J., Chen, F., & Wu, G. (2023) · The ISME Journal · doi:10.1038/s41396-023-01483-0 · Cited by 127
Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome
Du, Q., Wang, Q., Fan, H., Wang, J., Liu, X., Wang, H., Wang, Y., & Hu, R. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.017 · Cited by 119
Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism
Ayres, J. S. (2016) · Cell · doi:10.1016/j.cell.2016.05.049 · Cited by 110
Spalinger, M. R., Manzini, R., Hering, L., Riggs, J. B., Gottier, C., Lang, S., Atrott, K., Fettelschoss‐Gabriel, A., Olomski, F., Kündig, T. M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.052 · Cited by 116
“…and metastasis (Nieto et al., 2016); IL-1b, alone or in concert with IL-6, drives tumor angiogenesis (Voronov et al., 2003); and several studies have shown a tumor-promoting role for IL-1b/inflammasomes in the context of colitis-associated tumors (Allen et al., 2010; Bauer et al., 2012).”
BackgroundInfluentialGut Microbiota Protects against Gastrointestinal Tumorigenesis Caused by Epithelial Injury
Zhan, Y., Chen, P.-J., Sadler, W. D., Wang, F., Poe, S., Núñez, G., Eaton, K. A., & Chen, G. Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0827 · Cited by 107
“For example, other bacterial sensingmechanisms such as through the NLRs are also important for promoting wound repair and curtailing aberrant inflammatory responses during colitis-associated tumorigenesis (5, 6, 19, 20, 22, 23, 38, 39).”
BackgroundNOD‐like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD
Ohashi, K., Wang, Z., Yang, Y. M., Billet, S., Tu, W., Pimienta, M., Cassel, S. L., Pandol, S. J., Lu, S. C.-L., Sutterwala, F. S., et al. (2019) · Hepatology · doi:10.1002/hep.30693 · Cited by 115
Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment
Thi, H. T. H., & Hong, S. (2017) · Journal of Cancer Prevention · doi:10.15430/jcp.2017.22.2.62 · Cited by 125
“The reduction of IL-18 expression in NLRP3 or NLRP6 deficient mice indicated the pro-tumorigenic activity of NLRP3 in colon carcinogenesis.(52,53,60) Additionally, treatment of recombinant IL-18 can rescue the colitis-induced injuries and suppress the colitis-associated carcinogenesis in NLRP3−/− mice.”
BackgroundENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
Scambler, T., Jarosz-Griffiths, H., Reyna, S. J. L., Pathak, S., Wong, C., Holbrook, J. A., Martinon, F., Savic, S., Peckham, D. G., & McDermott, M. (2019) · eLife · doi:10.7554/elife.49248 · Cited by 117
“, 2018); however, NLRP3 activation exercises a protective role in animal models of induced colitis (Allen et al., 2010), running contrary to the expectation that reduced NLRP3 expression might reduce inflammation in the bowel.”
BackgroundConforti‐Andreoni, C., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.81 · Cited by 123
NLRP3 Inflammasome and Pathobiology in AMD
Celkova, L., Doyle, S., & Campbell, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010172 · Cited by 104
“In line with these findings, it was previously suggested that IL-18 might be protective in other diseases, such as experimental colitis and colorectal cancer in mice [95–98].”
ResultThe NAIP/NLRC4 inflammasome in infection and pathology
Bauer, R., & Rauch, I. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100863 · Cited by 115
Complex Roles of Caspases in the Pathogenesis of Inflammatory Bowel Disease
Becker, C., Watson, A. J. M., & Neurath, M. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.11.035 · Cited by 111
The impact of PKR activation: from neurodegeneration to cancer
Marchal, J. A., Lopez, G. J., Peran, M., Comino, A., Delgado, J. R., García‐García, J. A., Conde, V., Aranda, F. M., Rivas, C., Esteban, M., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-248294 · Cited by 104
“The inhibition of inflammasomes or neutralization of their products, mainly IL-1b and IL-18, has profound effects on carcinogenesis and tumor progression (100).”
BackgroundInflammasomes in Inflammation-Induced Cancer
Lin, C., & Zhang, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00271 · Cited by 120
“Independent research groups confirmed that Nlrp3-deficient mice were more susceptible to DSS-induced colitis and relevant symptoms like weigh loss were more severe (164, 165).”
BackgroundInfluentialMason, D. R., Beck, P. L., & Muruve, D. A. (2012) · Journal of Innate Immunity · doi:10.1159/000334247 · Cited by 105
Wu, H. L., Yang, F., Li, L.-H., Rao, Y. K., Ju, T., Wong, W.-T., Hsieh, C., Викторович, П. М., Hua, K., & Wu, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-36411-2 · Cited by 107
Lee, H., Lee, J. Y., Yang, G., Kang, H. C., Cho, Y., Lee, H. S., & Lee, J. Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-48794-x · Cited by 111
Demon, D., Kuchmiy, A., Fossoul, A., Zhu, Q., Kanneganti, T.-D., & Lamkanfi, M. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.36 · Cited by 102
“Importantly, caspase-11 -/- mice were hypersusceptible to DSS-induced colitis, suggesting that the reported hypersusceptible phenotype of caspase-1 -/- /11 -/- mice to DSS-induced colitis 6, 7, 14 may - at least in part - be due to deficient caspase-11 expression.”
InfluentialKarki, R., Malireddi, R. K. S., Zhu, Q., & Kanneganti, T. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1317414 · Cited by 109
“NLRC3 does not regulate inflammasome activation Certain members of the NLR family can form inflammasome complexes.19 Inflammasome-mediated caspase-1 activation during dextran sulfate sodium (DSS)–induced colitis is protective against colitis and colitis-associated tumorigenesis, particularly through the production of…”
BackgroundIntegrative inflammasome activity in the regulation of intestinal mucosal immune responses
Elinav, E., Henao‐Mejia, J., & Flavell, R. A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.115 · Cited by 107
“Allen et al.51 also demonstrated that Nlrp3 / mice had increased disease outcome, morbidity, histopathology, and polyp formation.”
BackgroundMethodResultInfluentialThe emerging roles of inflammasome‐dependent cytokines in cancer development
Gorp, H. V., & Lamkanfi, M. (2019) · EMBO Reports · doi:10.15252/embr.201847575 · Cited by 104
Nod-like receptors in the control of intestinal inflammation
Rubino, S. J., Selvanantham, T., Girardin, S. E., & Philpott, D. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.04.010 · Cited by 112
MyD88 and its divergent toll in carcinogenesis
Salcedo, R., Cataisson, C., Hasan, U., Yuspa, S. H., & Trinchieri, G. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.008 · Cited by 94
Shaker, M. E., Ashamallah, S. A., & Houssen, M. E. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.12.007 · Cited by 100
Kay, C., Wang, R., Kirkby, M., & Man, S. M. (2020) · Immunological Reviews · doi:10.1111/imr.12906 · Cited by 97
Dubey, S. R., Turnbull, C., Pandey, A., Zhao, A., Kurera, M., Al-Zidan, R. N., Shen, C. X., Gautam, M., Mahajan, S., Jadhav, P. S., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01354-y · Cited by 115
Specific inflammasomes in complex diseases
Masters, S. L. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.12.006 · Cited by 102
Flores, B., O’Connor, A., & Moss, A. C. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.07.028 · Cited by 99
“Aalykke et al 2015 No HIA; No OR/RR of CA Albert et al 1989 No HIA Allen et al 2010 No HIA; No OR/RR of CA Awais et al 2009 No HIA Baars et al 2011 No HIA Bergeron et al 2010 Mixed CD and UC; No HIA Bernstein 2006 Mixed CD and UC; No HIA Biasco et al 1995 No HIA Binder 1989 No HIA Blackstone et al 1981 No HIA Bresseno…”
The role of the microbiome and the NLRP3 inflammasome in the gut and lung
Donovan, C., Liu, G., Shen, S., Marshall, J. E., Kim, R., Alemao, C. A., Budden, K. F., Choi, J. P., Kohonen‐Corish, M. R. J., El-Omar, E. M., et al. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0720-472rr · Cited by 100
Stress Responses from the Endoplasmic Reticulum in Cancer
Kato, H., & Nishitoh, H. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00093 · Cited by 102
“These findings indicate that the NLRP3 inflammasome has antitumor functions (175).”
BackgroundInflammasome activation and Th17 responses
Deng, J., Yu, X.-Q., & Wang, P.-H. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.024 · Cited by 93
Hughes, M. M., Hooftman, A., Angiari, S., Tummala, P., Zaslona, Z., Runtsch, M. C., McGettrick, A. F., Sutton, C. E., Diskin, C., Rooke, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.072 · Cited by 90
Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
Missiroli, S., Perrone, M., Boncompagni, C., Borghi, C., Campagnaro, A., Marchetti, F., Anania, G., Greco, P., Fiorica, F., Pinton, P., et al. (2021) · Cancers · doi:10.3390/cancers13102297 · Cited by 97
Cheng, H.-Y., Hsieh, C.-H., Lin, P., Chen, Y.-T., Hsu, D. S., Tai, S., Chu, P., & Yang, M. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004832 · Cited by 102
Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis
Allen, I. C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00169 · Cited by 103
Self-citationInflammasome signaling in colorectal cancer
Sharma, B. R., & Kanneganti, T. (2022) · Translational research · doi:10.1016/j.trsl.2022.09.002 · Cited by 103
Li, X.-D., Chiu, Y., Ismail, A. S., Behrendt, C. L., Wight‐Carter, M., Hooper, L. V., & Chen, Z. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107114108 · Cited by 105
“Recent studies also provide evidence that loss-of-function mutations of the inflammasome sensitize mice to DSS-induced colitis (23, 24).”
BackgroundRegulation of adaptive immunity by the NLRP3 inflammasome
Chen, M., Wang, H., Chen, W., & Meng, G. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.025 · Cited by 100
“cells (IEC) or immune cells, respectively [37–42].”
Uric Acid-Driven Th17 Differentiation Requires Inflammasome-Derived IL-1 and IL-18
Conforti‐Andreoni, C., Spreafico, R., Qian, H. L., Riteau, N., Ryffel, B., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101408 · Cited by 105
“Similarly contradictory data describe the function of the NLRP3 inflammasome in mouse models of colitis and colitis-associated colon cancer (48, 49).”
BackgroundInflammasomes of the intestinal epithelium
Sellin, M. E., Maslowski, K. M., Maloy, K. J., & Hardt, W. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.06.002 · Cited by 101
Chen, Y., Le, T. H., Du, Q., Zhao, Z., Liu, Y., Zou, J., Hua, W., Liu, C., & Zhu, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.021 · Cited by 93
Zeng, B., Huang, Y., Chen, S., Xu, R., Xu, L., Qiu, J.-H., Shi, F., Liu, S., Zha, Q., Ouyang, D., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00891-0 · Cited by 93
“However, several studies have shown that the NLRP3 inflammasome may have protective effects against DSS-induced colitis [24, 25].”
BackgroundInflammasome: structure, biological functions, and therapeutic targets
Dai, Y., Zhou, J., & Shi, C. (2023) · MedComm · doi:10.1002/mco2.391 · Cited by 98
Yao, Y., Chen, S., Cao, M., Fan, X., Yang, T., Huang, Y., Song, X., Li, Y., Ye, L., Shen, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms15402 · Cited by 93
MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
Tezcan, G., Martynova, E. V., Gilazieva, Z. E., McIntyre, A., Rizvanov, A. A., & Khaiboullina, S. F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00451 · Cited by 85
Activation of Pyroptotic Cell Death Pathways in Cancer: An Alternative Therapeutic Approach
Kanipandian, N., Kannan, S., Thorne, R. F., Li, D., & Li, D. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.04.010 · Cited by 94
“Unlike Nlrp3, the Nlrp1 and Nlrc4 inflammasomes are activated for a more limited set of bacterial components [47,64,65,70]; hence, Nlrp3 has been extensively studied for therapeutic purposes [45].”
BackgroundEpigenetic Mechanisms of Inflammasome Regulation
Poli, G., Fabi, C., Bellet, M. M., Costantini, C., Nunziangeli, L., Romani, L., & Brancorsini, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165758 · Cited by 80
“Products of inflammasome activation (IL-1β and IL-18) behave as protumorigenic factors in gastrointestinal cancers, while the protective role of NLRP6 against tumor development has been clarified [75], whereas, for NLRC4, contrasting findings were reported [76,77].”
ResultImmunoregulation by the gut microbiota
Nishio, J., & Honda, K. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0993-6 · Cited by 95
Inflammasome: Cancer's friend or foe?
Terlizzi, M., Casolaro, V., Pinto, A., & Sorrentino, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.002 · Cited by 97
Xu, Y., Li, H., Chen, W., Yao, X., Xing, Y., Wang, X., Zhong, J., & Meng, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077955 · Cited by 96
“although controversy exists from different models [16,17].”
Yue, B., Luo, X., Yu, Z., Mani, S., Wang, Z., & Dou, W. (2019) · Microorganisms · doi:10.3390/microorganisms7100440 · Cited by 94
Divergent functions of NLRP3 inflammasomes in cancer: a review
Shadab, A., Mahjoor, M., Abbasi‐Kolli, M., Afkhami, H., Moeinian, P., & Safdarian, A.-R. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01235-9 · Cited by 87
“On the other hand, the NLRP3 inflammasome can inhibit tumorigenesis in colitis-associated cancer [23].”
BackgroundGatault, S., Delbeke, M., Driss, V., Sarazin, A., Dendooven, A., Kahn, J., Lefèvre, G., & Capron, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402914 · Cited by 88
cGAS restricts colon cancer development by protecting intestinal barrier integrity
Hu, S., Fang, Y., Chen, X., Cheng, T., Zhao, M., Du, M., Li, T., Li, M., Zeng, Z., Wei, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105747118 · Cited by 85
Deswaerte, V., Nguyen, P. M., West, A. C., Browning, A. F., Yu, L., Ruwanpura, S. M., Balic, J. J., Livis, T., Girard, C., Preaudet, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1887 · Cited by 91
Involvement of inflammasomes in tumor microenvironment and tumor therapies
Zhang, Z., Li, X., Wang, Y., Wei, Y., & Wei, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01407-7 · Cited by 88
“In colitisassociated cancer models, mice lacking ASC, caspase-1, or NLRP3 show more severe colitis and accentuated tumorigenesis [136].”
BackgroundImplication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Singh, S., Sharma, P., Sarma, D. K., Kumawat, M., Tiwari, R. R., Verma, V., Nagpal, R., & Kumar, M. (2023) · Cancers · doi:10.3390/cancers15061913 · Cited by 91
Yang, Q., Yu, C., Yang, Z., Wei, Q., Mu, K., Zhang, Y., Zhao, W., Wang, X., Huai, W., & Han, L. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130310 · Cited by 85
Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis
Chen, G. (2014) · European Journal of Immunology · doi:10.1002/eji.201344135 · Cited by 92
Beyond IgE: Alternative Mast Cell Activation Across Different Disease States
Lyons, D. O., & Pullen, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041498 · Cited by 88
Inflammasome inhibitors: promising therapeutic approaches against cancer
Xu, S., Li, X., Liu, Y., Xia, Y., Chang, R., & Zhang, C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0755-0 · Cited by 86
Peng, Y., He, Y., Chen, C., Xu, T., Li, L., Ni, M.-M., Meng, X., Huang, C., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.006 · Cited by 82
Microbiota as a mediator of cancer progression and therapy
Pope, J. L., Tomkovich, S., Yang, Y., & Jobin, C. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.021 · Cited by 79
Self-citationRole of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review
Lang, Y., Chu, F., Shen, D., Zhang, W., Zheng, C., Zhu, J., & Cui, L. (2018) · Mediators of Inflammation · doi:10.1155/2018/1549549 · Cited by 79
“Moreover, inflammasomes are capable of maintaining the balance of the gut microflora and prevent enteritis from progressing to a tumor [22].”
BackgroundNOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79
“Equally, lack of epithelial IL-18 expression in NLRP3 deficient mice enhanced susceptibility of these mice to DSS-induced colitis when compared to control wild-type mice [265,267,268].”
BackgroundBeneficial and Detrimental Roles of NLRs in Carcinogenesis
Janowski, A. M., Kolb, R. H., Zhang, W., & Sutterwala, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00370 · Cited by 84
“NLRP3 AND CANCER NLRP3, like NLRC4 and NLRP6, is important for prevention of CAC development in the AOM-DSS model (13, 14).”
BackgroundDynamic roles of inflammasomes in inflammatory tumor microenvironment
Jang, J., Kim, D., & Surh, Y. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00154-7 · Cited by 86
“Allen et al.(43) reported suppressive effects of Pycard and Casp1 as well as Nlrp3, on acute and recurring colitis induced by DSS, and found that Pycard and caspase-1 were essential for survival in AOM plus DSS-induced CAC mouse model.”
BackgroundThe Emerging Role of Vitamin B6 in Inflammation and Carcinogenesis
Bird, R. P. (2018) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2017.11.004 · Cited by 83
“For example, inflammasome NLRP3 could be involved as a negative or positive effecter of tumor growth (Allen et al., 2010; Bauer et al., 2010; Zivoget et al., 2012).”
BackgroundEpithelial NAIPs protect against colonic tumorigenesis
Allam, R., Maillard, M. H., Tardivel, A., Chennupati, V., Bega, H., Yu, C. W., Velin, D., Schneider, P., & Maslowski, K. M. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140474 · Cited by 71
“Additionally, NAIPs belong to the NLR family, and several NLRs are protective in colonic inflammation and tumorigenesis, through a variety of mechanisms (Allen et al., 2010; Hu et al., 2010; Chen et al., 2011; Elinav et al., 2011; Zaki et al., 2011; Carvalho et al., 2012).”
BackgroundResultAhn, H., Jeon, E., Kim, J., Kang, S. G., Yoon, S., Ko, H., Kim, P.-H., & Lee, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01462-4 · Cited by 80
Expression and functional importance of innate immune receptors by intestinal epithelial cells
Marques, R., & Boneca, I. G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0829-9 · Cited by 76
“However, in the chronic azoxymethane (AOM)/DSS model of colitis, reconstitution of NLRP3-deficient mice with wild type bone marrow was shown to confer resistance against colon tumorigenesis [79] demonstrating a protective role of NLRP3 inflammasome signaling in myeloid cells.”
BackgroundIntegrin-Mediated First Signal for Inflammasome Activation in Intestinal Epithelial Cells
Thinwa, J., Segovia, J. A., Bose, S., & Dube, P. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400145 · Cited by 74
A model for cancer-suppressive inflammation
Haabeth, O. A. W., Bogen, B., & Corthay, A. (2012) · OncoImmunology · doi:10.4161/onci.21542 · Cited by 81
Role of Inflammasomes in Intestinal Inflammation and Crohnʼs Disease
Opipari, A. W., & Franchi, L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000230 · Cited by 84
NLRP3 promotes inflammation‐induced skin cancer but is dispensable for asbestos‐induced mesothelioma
Chow, M. T., Tschopp, J., Möller, A., & Smyth, M. J. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2012.46 · Cited by 74
NOD-Like Receptors: Guardians of Intestinal Mucosal Barriers
Claes, A.-K., Zhou, J. Y., & Philpott, D. J. (2015) · Physiology · doi:10.1152/physiol.00025.2014 · Cited by 68
“Some studies show that mice deficient in NLRP3 are more susceptible to dextran sulphate sodium (DSS) colitis, 2,4,6-trinitrobenzenesulfonic acid (TNBS), and azoxymethane (AOM)/DSS-induced colorectal cancer, which correlates, for example, with reduced IL-1 , IL-18, and TGF- levels (1, 40, 115).”
BackgroundCarvalho, F. A., Nalbantoglu, I., Ortega-Fernandez, S., Aitken, J. D., Su, Y., Koren, O., Walters, W. A., Knight, R., Ley, R. E., Vijay-Kumar, M., et al. (2012) · Gut · doi:10.1136/gut.2011.240556 · Cited by 73
miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells
Wan, L., Yuan, X., Liu, M., & Xue, B. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5667 · Cited by 80
“This type of role was also reported in colitis-associated cancer (17).”
The machinery of Nod‐like receptors: refining the paths to immunity and cell death
Saleh, M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01045.x · Cited by 71
Differential role of the NLRP 3 inflammasome in infection and tumorigenesis
Tartey, S., & Kanneganti, T. (2019) · Immunology · doi:10.1111/imm.13046 · Cited by 77
Gut microbiota, NLR proteins, and intestinal homeostasis
Guo, H., Gibson, S. A., & Ting, J. P. ‐. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20181832 · Cited by 77
Self-citationEndoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases
Guo, B., & Li, Z. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00242 · Cited by 73
“A study by Allen et al. (2010) showed that NLRP3-deficient mice were more sensitive”
BackgroundNLRPs, microbiota, and gut homeostasis: unravelling the connection
Zambetti, L. P., & Mortellaro, A. (2014) · The Journal of Pathology · doi:10.1002/path.4357 · Cited by 69
“Nlrp3−/− mice undergoing this protocol exhibited increased epithelial dysplasia and greater tumour burden in the colon compared with wild-type animals [24,39].”
BackgroundInfluentialKoblansky, A. A., Truax, A. D., Liu, R., Montgomery, S. A., Ding, S., Wilson, J. E., Brickey, W. J., Mühlbauer, M., McFadden, R.-M. T., Hu, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.064 · Cited by 79
“and the presence of blood in the stool (Allen et al., 2010) was significantly higher inNlrx1 / animals compared to WT controls (Figure 1C).”
InfluentialSelf-citationThe strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
Jiang, H., Gong, T., & Zhou, R. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.003 · Cited by 74
Microbes and Inflammation in Colorectal Cancer
Kostic, A. D., Chun, E., Meyerson, M., & Garrett, W. S. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0101 · Cited by 69
“Similar phenotypes are seen in mice deficient in NLR family members Nlrp3 (28, 29) and Nlrp12”
Updating the NLRC4 Inflammasome: from Bacterial Infections to Autoimmunity and Cancer
Wen, J., Xuan, B., Liu, Y., Wang, L., He, L., Meng, X., Zhou, T., & Wang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702527 · Cited by 78
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
Khan, M. B., Ai, M.-L., Du, K., Song, J., Wang, B., Lin, J., Ren, A., Chen, C., Huang, Z., Qiu, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1062225 · Cited by 73
Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis
Ding, Y., Wang, Z., Chen, Y., Guo, Q., & Dong, Y. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.03.017 · Cited by 73
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Tengesdal, I. W., Dinarello, C. A., & Marchetti, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108545 · Cited by 78
Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis
Henderson, C., & Goldbach‐Mansky, R. T. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833ceff4 · Cited by 76
Emerging Significance of NLRs in Inflammatory Bowel Disease
Davis, B. K., Philipson, C., Hontecillas, R., Eden, K., Bassaganya-Riera, J., & Allen, I. C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000151 · Cited by 67
Self-citationNonessential Role for the NLRP1 Inflammasome Complex in a Murine Model of Traumatic Brain Injury
Brickler, T., Gresham, K., Meza, A., Coutermarsh-Ott, S., Williams, T. M., Rothschild, D. E., Allen, I. C., & Theus, M. H. (2016) · Mediators of Inflammation · doi:10.1155/2016/6373506 · Cited by 72
Self-citationSeregin, S. S., Golovchenko, N., Schaf, B., Chen, J., Eaton, K. A., & Chen, G. Y. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.55 · Cited by 67
Jamali, A., Hu, K., Sendra, V. G., Blanco, T., Lopez, M. J., Ortiz, G., Qazi, Y., Zheng, L., Turhan, A., Harris, D. L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108099 · Cited by 70
“4 h later, their BMs were reconstituted by intravenous administration of 5 × 106 BM cells obtained from femurs and tibias of BDCA2-DTR and Treg FM mice strains at a 2:1 ratio (Brown and Reiner, 2000; Allen et al., 2010).”
MethodNLRP3 inflammasome in health and disease (Review)
Wang, H., Ma, L., Su, W., Liu, Y., Xie, N., & Liu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5489 · Cited by 76
Dupaul-Chicoine, J., Dagenais, M., & Saleh, M. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828dcac7 · Cited by 78
Duerr, C. U., & Hornef, M. W. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.11.002 · Cited by 75
“Beside inflammation, mucosal injury in the absence of Nlrp3 and Nlrc4 was shown to affect epithelial turn-over and promote cancerogenesis [98,109].”
BackgroundInfluential
Metadata
- Authors
- Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Lineberger Comprehensive Cancer Center 1 , 2 , 3 , 4 , 5 , 6 , 7
- Corresponding author
- Ting, Jenny P.-Y.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-04-12
- Volume
- 207
- Issue
- 5
- Pages
- 1045-1056
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2867287
- OpenAlex
- W2058590329
- Cited by
- 826
- References
- 44
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 54 · 2023: 54 · 2022: 66 · 2021: 53 · 2020: 43 · 2019: 55 · 2018: 54 · 2017: 61 · 2016: 45 · 2015: 56 · 2014: 51 · 2013: 62 · 2012: 49
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (2t32ar007416-25)
- National Cancer Institute (T32CA009156)
- National Institute of Allergy and Infectious Diseases (F32AI082895, U19AI077437, U19-AI077437-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073338, P30‐DK34987, P30DK034987)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32-AR007416)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD046369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, colitis-associated colorectal cancer, inflammatory bowel disease, carcinogenesis, caspase-1, IL-1β, IL-18, NLRP3 knockout mice, NLRC4, hematopoietic cells, bone marrow reconstitution, DSS-induced colitis, azoxymethane, intestinal polyps
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Colitis, Colon, Cytoskeletal Proteins, Euthanasia, Humans, Neoplasms, Inflammatory Bowel Diseases, Gene Expression Regulation, Neoplastic, Mice, Knockout, Interleukin-18, Tumor Burden, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.